Condition 1: Myopia correction by photorefractive keratectomy. Condition 2: Astigmatism correction by photorefractive keratectomy. Myopia, unspecified eye Unspecified astigmatism
Conditions
Interventions
Intervention 1: Intervention group: One eye in each subject was randomly allocated to use of 0.1% Fluorometholone eye drops packaged in droppers (Floucort®, SinaDarou Co., Tehran, Iran) that was presc
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Stable refraction error for at least 12 months Myopia between -8.0 to -1.0 diopters Astigmatism less than 4.0 diopters Normal eye examination
Exclusion criteria
Exclusion criteria: Unwillingness to participate or continue administration of another topical medication need to increase the topical steroid dosage treatment-related complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in best corrected distance visual acuity (BCDVA). Timepoint: Before intervention and on days one, three, and five and then at months one and three postoperatively. Method of measurement: Eye examination, slit-lamp biomicroscopy and fundus examination assessment.;Corneal optical density. Timepoint: Before intervention and on days one, three, and five and then at months one and three postoperatively. Method of measurement: Corneal densitometry was performed with a rotating camera cornea tomography system (Pentacam®). | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: Before intervention and on days one, three, and five and then at months one and three postoperatively. Method of measurement: Goldman applanation tonometry (GAT).;Side effects. Timepoint: On days one, three, and five and then at months one and three postoperatively. Method of measurement: Clinical assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Pourazizi
Esfahan University of Medical Sciences
Outcome results
None listed